A citation-based method for searching scientific literature

Wen-Jie Li, Xing-Qing Chen, Ling-Ling Xu, Yuan-Qing Li, Bi-Hui Luo. Cardiovasc Diabetol 2020
Times Cited: 49



James P Curtain, Kieran F Docherty, Pardeep S Jhund, Mark C Petrie, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Olof Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, Scott D Solomon, John J V McMurray. Eur Heart J 2021
Times Cited: 45




List of shared articles



Times cited

Mechanisms Underlying Antiarrhythmic Properties of Cardioprotective Agents Impacting Inflammation and Oxidative Stress.
Katarina Andelova, Barbara Szeiffova Bacova, Matus Sykora, Peter Hlivak, Miroslav Barancik, Narcis Tribulova. Int J Mol Sci 2022
6


Association between Empagliflozin Use and Electrocardiographic Changes.
Daniel Antwi-Amoabeng, Sunil Sathappan, Bryce D Beutler, Mark B Ulanja, Munadel Awad, Nageshwara Gullapalli, Phillip Duncan, T David Gbadebo. Clin Pract 2022
0

Benefits of SGLT2 inhibitors in arrhythmias.
Jinghan Gao, Genlong Xue, Ge Zhan, Xinying Wang, Jiatian Li, Xiaolei Yang, Yunlong Xia. Front Cardiovasc Med 2022
0

Sodium-glucose cotransporter type 2 inhibitors and cardiac arrhythmias.
Antonis A Manolis, Theodora A Manolis, Helen Melita, Antonis S Manolis. Trends Cardiovasc Med 2022
3

Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling.
Jinchun Wu, Tao Liu, Shaobo Shi, Zhixing Fan, Roddy Hiram, Feng Xiong, Bo Cui, Xiaoling Su, Rong Chang, Wei Zhang,[...]. Cardiovasc Diabetol 2022
1